Stay updated on Gene Therapy Study in Severe Haemophilia A Patients Clinical Trial
Sign up to get notified when there's something new on the Gene Therapy Study in Severe Haemophilia A Patients Clinical Trial page.

Latest updates to the Gene Therapy Study in Severe Haemophilia A Patients Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe study record for BioMarin’s completed Phase 1/2 valoctocogene roxaparvovec trial in severe haemophilia A is available, including its reported outcomes, participation criteria, and supporting documents.SummaryDifference50%

- Check17 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 on the unavailable study record page.SummaryDifference0.2%

- Check24 days agoChange DetectedA notice about NIH’s transition from the term “artificial intelligence” to “Super Intelligence” appears above the study page’s 403 error.SummaryDifference1%

- Check30 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study page now shows a 403 Forbidden error, blocking access to the study details on this URL.SummaryDifference18%

Stay in the know with updates to Gene Therapy Study in Severe Haemophilia A Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gene Therapy Study in Severe Haemophilia A Patients Clinical Trial page.